Oglesby A - Search Results

1

Intervention thresholds for osteoporosis.

Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jönsson B. Kanis JA, et al. Among authors: oglesby a. Bone. 2002 Jul;31(1):26-31. doi: 10.1016/s8756-3282(02)00813-x. Bone. 2002. PMID: 12110408

2

The components of excess mortality after hip fracture.

Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. Kanis JA, et al. Among authors: oglesby ak. Bone. 2003 May;32(5):468-73. doi: 10.1016/s8756-3282(03)00061-9. Bone. 2003. PMID: 12753862

3

Optimization of BMD measurements to identify high risk groups for treatment--a test analysis.

Johansson H, Oden A, Johnell O, Jonsson B, de Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA. Johansson H, et al. Among authors: oglesby a. J Bone Miner Res. 2004 Jun;19(6):906-13. doi: 10.1359/jbmr.2004.19.6.906. J Bone Miner Res. 2004. PMID: 15190881 Free article.

4

The health care costs of diabetic nephropathy in the United States and the United Kingdom.

Gordois A, Scuffham P, Shearer A, Oglesby A. Gordois A, et al. Among authors: oglesby a. J Diabetes Complications. 2004 Jan-Feb;18(1):18-26. doi: 10.1016/S1056-8727(03)00035-7. J Diabetes Complications. 2004. PMID: 15019595

5

Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S.

Shearer A, Scuffham P, Gordois A, Oglesby A. Shearer A, et al. Among authors: oglesby a. Diabetes Care. 2003 Aug;26(8):2305-10. doi: 10.2337/diacare.26.8.2305. Diabetes Care. 2003. PMID: 12882853

6

The health care costs of diabetic peripheral neuropathy in the US.

Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. Gordois A, et al. Among authors: oglesby a. Diabetes Care. 2003 Jun;26(6):1790-5. doi: 10.2337/diacare.26.6.1790. Diabetes Care. 2003. PMID: 12766111

7

The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.

Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL. Oglesby AK, et al. J Rheumatol. 2003 Jul;30(7):1579-83. J Rheumatol. 2003. PMID: 12858462 Clinical Trial.

8

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.

Ray JA, Valentine WJ, Secnik K, Oglesby AK, Cordony A, Gordois A, Davey P, Palmer AJ. Ray JA, et al. Among authors: oglesby ak. Curr Med Res Opin. 2005 Oct;21(10):1617-29. doi: 10.1185/030079905X65349. Curr Med Res Opin. 2005. PMID: 16238902 Review.

9

Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.

Shetty S, Secnik K, Oglesby AK. Shetty S, et al. J Manag Care Pharm. 2005 Sep;11(7):559-64. doi: 10.18553/jmcp.2005.11.7.559. J Manag Care Pharm. 2005. PMID: 16137213 Free PMC article.

10

Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Hayes C, Oglesby A, Spinas GA. Palmer AJ, et al. Among authors: oglesby a. Curr Med Res Opin. 2004 Aug;20 Suppl 1:S53-8. doi: 10.1185/030079903125002611. Curr Med Res Opin. 2004. PMID: 15324516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters